Opioid addicts turning to loperamide to get high

Published On 2018-10-15 14:50 GMT   |   Update On 2021-08-23 12:27 GMT

According to reports Opioid addicts in US have turned to a dangerous and potentially deadly measure: taking loperamide, a common diarrhoea medicine to get high. The misuse of Loperamide, which is sold under the brand name Imodium, could lead to lethal results.


When addicts don't get the prescriptions they use to be getting because of the crackdown on opioids, they resort to using loperamide. The addicts at times are also scared about the situation with heroin and fentanyl in the streets.


Too many Imodium caplets may produce a euphoric feeling but it disrupts electrical pathways of heart and at extremely high doses it can cause QTc prolongation and other fatal arrhythmia.The cases of overdose have been recently published in the Annals of Emergency Medicine involving use of loperamide by opioid addicts.


The US Food and Drug Administration (FDA) has been issuing a safety warning from time to time against loperamide available as a prescription or over-the-counter (OTC) medication.


Imodium is approved to control symptoms of diarrhoea, including travellers' diarrhoea. In June 2016, the FDA issued a warning about the risk of serious heart problems with high doses of loperamide, including high doses from abuse and misuse. Now, the agency is working to change the medication's packaging to encourage safe use.


Also Read: Importance of ORS in saving children From Diarrhea


According to FDA, it continues to receive reports of serious heart problems, including severe heart problems and deaths which is linked to higher-than-recommended doses of loperamide. These reports are primarily among those who have intentionally misused or abused loperamide.


The recommended maximum dose for adults is 8 milligrams per day for OTC use and 16 mg per day for prescription use. Loperamide is safe when taken as directed. Loperamide can be found OTC under the brand name Imodium A-D, as well as under other store brands and as a generic.


As a result of these continued reports, the FDA was working with manufacturers to implement blister packs or a type of single-dose packaging and reduce the number of doses in a package — all in the hope of encouraging safe use.


Also Read: Loperamide use :Safety announcement issued by USFDA

Patients and consumers should only take loperamide as directed by a health care professional or by the OTC drug label. Taking more than prescribed or more than the recommended dose can lead to severe heart problems or even death.


When taking OTC loperamide, if your diarrhoea lasts for more than two days, stop taking the medicine and contact your healthcare professional.


In light of such recent case reports and increased loperamide abuse, the FDA has issued a new safety warning for loperamide regarding its toxic effect on the heart.It has been recommended that Doctors must urge pharmacists and family members to be suspicious and ask questions of anyone buying large amounts of Imodium or similar products.


For further reference log on to :


Eggleston W, Clark KH, Marraffa JM. Loperamide abuse associated with cardiac dysrhythmia and death. Ann Emerg Med. 2016 Apr 26. pii: S0196-0644(16)30052-X. doi: 10.1016/j.annemergmed.2016.03.047.


FDA Drug Safety Communication: FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse [06-07-2016]. Available from:










Tags:    
Article Source : press release

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News